AMR vs ASH

Despite a strong Piotroski F-Score of 7/9 indicating solid financial health on certain fundamentals, AMR faces significant challenges including negative profitability metrics, declining revenue, and a lack of Altman Z-Score to confirm financial stability. The stock trades at a high forward P/E of 10.82 amid negative earnings trends and collapsing year-over-year EPS growth of -244.8%, while insiders have shown bearish sentiment with $3.81M in net sales. Analysts recommend 'buy' but with limited consensus (only 2 analysts), and technical trend is deeply bearish at 10/100. The extreme 5-year price surge of +1710.4% appears disconnected from deteriorating fundamentals, raising sustainability concerns.

The Advanced Deterministic Scorecard reveals a deeply concerning financial profile with a Piotroski F-Score of just 2/9, indicating severe weakness in fundamental health. Despite a reasonable forward P/E of 13.53 and a 2.63% dividend yield, the company is plagued by a negative profit margin (-46.33%) and ROE (-34.45%), driven by a catastrophic earnings miss in Q3 2025. While the technical trend shows short-term recovery (+25.4% over 6M), long-term performance remains weak (-38.5% over 3Y), and analyst targets offer only marginal upside. Persistent earnings disappointment, lack of insider support, and deteriorating profitability undermine any value proposition.